摘要
目的本研究旨在观察不同调查方法时哮喘患者药物治疗和病情控制调查结果。方法共200例(男112例,女88例)哮喘患者参与了问卷调查,内容包括患者最近1年及最近1个月的病情严重程度,病情控制状况和患者对病情的自我评价进行。结果最近1年,127例(63.5%)曾不同时间处于中重度持续状态的患者中,51例(40.2%)按照GINA方案使用长效β2-受体激动剂+吸入表面激素。最近1个月处于中重度持续状态的86例(43.0%)患者,使用长效β2-受体激动剂+吸入表面激素的有29例(33.7%)。在自我评价最近1个月达到完全控制或良好控制的106例患者中,处于间歇状态的为47.2%,52.8%处于不同程度的慢性持续状态。约73.5%的患者最近1个月曾处于慢性持续状态。结论对哮喘患者的病情评价应结合最近1个月与最近1年不同时间的病情状况,目前哮喘患者对于自身病情控制自我评价与其实际病情控制状态严重不符,说明有很大一部分患者不能正确评价自己的病情,必须由医生监督并调整患者的吸入激素用量。
【Objective】To asscess the quality of asthma treatment and control by different survey methods.【Methods】Following recruitment,face to face interviews were completed with 200 adults(112 males,88 famales)with diagnosed asthma,who had current symptoms or were using asthma medication.Asthma severity,asthma control and self-assessment were assessed in the last month and the last year.【Results】Totally 127 patients(63.5%)had moderate or severe asthmatics in the last year,and 51 patients(40.2%)used ICS+long actionβ2 receptor agonist for treatment.Eighty-six patients(43.0%)had moderate or severe asthmatics in the last month,and 29 patient(33.7%)used ICS+long actionβ2 receptor agonist for treatment flowing GINA.In 106 patients who thought well or were completely controlled in the self-assessment questionnaire,52.8%were in different degrees of chronic persistent state.73.5%of the patients were in chronic persistent state in the last year.【Conclusion】The assessment of asthma control should be combined with asthma severity in the last month and the last year.The self-assessment of asthma control is highly better than the real asthma control.
作者
王法霞
梁结柱
张在勇
李斌恺
赖克方
WANG Faxia;LIANG Jiezhu;ZHANG Zaiyong;LI Binkai;LAI Kefang(Department of ICU,Guangzhou Panyu Central Hospital,Guangzhou,Guangdong 511400,China;Department of Cardiology,Guangzhou Panyu Central Hospital(Guangzhou Panyu Cardiovascular Disease Research Institute),Guangzhou,Guangdong 511400,China;Department of Geriatrics,Guangzhou First People's Hospital,Guangzhou,Guangdong 5106313,China;National Key Laboratory,the First Affiliated Hospital of Guangzhou Medical University(Guangzhou Institute of Respiratory Diseases),Guangzhou,Guangdong 510631,China)
出处
《中国医学工程》
2021年第4期30-33,共4页
China Medical Engineering
关键词
哮喘
调查方案
病情控制
asthma
survey plan
disease control
